Perivascular space imaging during therapy for medulloblastoma.

Ruitian Song, John O Glass, Shengjie Wu, Yimei Li, Giles W Robinson, Amar Gajjar, Thomas E Merchant, Wilburn E Reddick
Author Information
  1. Ruitian Song: Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
  2. John O Glass: Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
  3. Shengjie Wu: Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
  4. Yimei Li: Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
  5. Giles W Robinson: Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
  6. Amar Gajjar: Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
  7. Thomas E Merchant: Radiation Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
  8. Wilburn E Reddick: Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, Tennessee, United States of America. ORCID

Abstract

Perivascular spaces (PVS) are fluid filled compartments surrounding the small blood vessels in the brain. The impact of radiotherapy and chemotherapy on PVS remains unclear. The aim of this study is to investigate treatment effects of radiotherapy and chemotherapy at four time points (TPs) in pediatric medulloblastoma (MB) patients. We examined 778 scans from 241 MB patients at baseline (0M), after 12 weeks (about 3 months) of radiotherapy and rest (3M), after chemotherapy completion (12M), and a follow-up (FollowUp) at 18- or 21-months post-baseline. PVS was segmented by applying Frangi filter on the white matter regions on T1 weighted images acquired at 3T Siemens MRI scanner using MPRAGE. PVS volume and ratio, defined as the ratio of PVS volume to the white matter volume, were measured at the four TPs. The data was first statistically analyzed using a full model where all data were included, then a paired model, which included only patients who completed consecutive measurements under the same anesthesia and shunt conditions. Both the full model and paired model showed that PVS (including ratio and volume) increased at 3M post-radiotherapy compared to baseline. During chemotherapy, PVS decreased significantly from 3M to 12M. Subsequently, from 12M to FollowUp, PVS increased again. MRI exams under anesthesia exhibited significantly lower PVS than those without anesthesia. Patients who had undergone a shunt procedure exhibited a significantly reduced PVS compared to those who had not undergone the procedure. We concluded that craniospinal irradiation led to an elevated PVS. Conversely, chemotherapy or time post-irradiation decreased PVS. Anesthesia and shunt procedures can also influence perivascular space ratio or volume.

References

  1. Neuron. 2022 Nov 2;110(21):3566-3581 [PMID: 36327898]
  2. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1999 Aug;21(4):307-10 [PMID: 12567456]
  3. Medicina (Kaunas). 2023 May 10;59(5): [PMID: 37241149]
  4. Brain. 2008 Sep;131(Pt 9):2332-40 [PMID: 18676439]
  5. World Neurosurg. 2020 Jun;138:436-439 [PMID: 32251809]
  6. Front Neuroanat. 2017 Nov 07;11:101 [PMID: 29163074]
  7. IEEE Trans Med Imaging. 2004 Feb;23(2):246-55 [PMID: 14964568]
  8. Eur Radiol. 2009 Apr;19(4):1011-8 [PMID: 18987865]
  9. Sci Rep. 2018 Feb 1;8(1):2132 [PMID: 29391404]
  10. Neuroimage. 2012 Aug 15;62(2):774-81 [PMID: 22248573]
  11. Front Neuroinform. 2021 Jun 18;15:641600 [PMID: 34262443]
  12. J Neurosci Methods. 2016 Jan 15;257:34-44 [PMID: 26416614]
  13. J Magn Reson Imaging. 2024 Feb;59(2):397-411 [PMID: 37658640]
  14. Neuroimage. 2023 May 1;271:120009 [PMID: 36907282]
  15. Invest Radiol. 2024 Jan 1;59(1):1-12 [PMID: 36897826]
  16. J Neurosurg. 2002 Jul;97(1):73-9 [PMID: 12134935]
  17. Front Neurol. 2022 Jan 04;12:789918 [PMID: 35082748]
  18. Neuroradiology. 2013 Aug;55(8):1049-1056 [PMID: 23673874]
  19. Radiology. 2010 Jan;254(1):210-8 [PMID: 20019142]
  20. Oncol Rep. 2002 Jul-Aug;9(4):683-8 [PMID: 12066192]
  21. Cancers (Basel). 2021 Nov 26;13(23): [PMID: 34885055]
  22. IEEE Access. 2019;7:18382-18391 [PMID: 30956927]
  23. IEEE Trans Biomed Eng. 2017 Dec;64(12):2803-2812 [PMID: 28362579]
  24. Neurology. 2022 Dec 12;99(24):e2648-e2660 [PMID: 36123122]
  25. Proc SPIE Int Soc Opt Eng. 2019 Mar;10949: [PMID: 31551645]
  26. Front Neurol. 2022 Feb 28;13:843883 [PMID: 35295837]
  27. J Alzheimers Dis. 2015;43(2):415-24 [PMID: 25096616]
  28. AJNR Am J Neuroradiol. 2005 Jun-Jul;26(6):1512-20 [PMID: 15956523]
  29. Clin Interv Aging. 2019 May 10;14:871-878 [PMID: 31190773]
  30. Lancet Neurol. 2018 Nov;17(11):1016-1024 [PMID: 30353860]
  31. Neuro Oncol. 1999 Jul;1(3):177-87 [PMID: 11550312]
  32. AJNR Am J Neuroradiol. 2018 Sep;39(9):1622-1628 [PMID: 30093484]
  33. Cereb Circ Cogn Behav. 2020;1:100002 [PMID: 33458712]
  34. Cerebrovasc Dis. 2015;39(3-4):224-31 [PMID: 25823458]
  35. Jpn J Radiol. 2017 Apr;35(4):172-178 [PMID: 28197821]
  36. Sci Rep. 2019 Aug 26;9(1):12351 [PMID: 31451792]
  37. Theranostics. 2018 Jan 1;8(3):710-722 [PMID: 29344300]
  38. Nat Rev Clin Oncol. 2011 Jun 28;8(9):540-9 [PMID: 21709698]
  39. AJNR Am J Neuroradiol. 2020 Nov;41(11):2139-2145 [PMID: 33033050]
  40. Front Neurol. 2022 May 03;13:844938 [PMID: 35592469]
  41. Indian J Radiol Imaging. 2018 Jul-Sep;28(3):373-374 [PMID: 30319219]
  42. AJNR Am J Neuroradiol. 2021 Aug;42(8):1543-1549 [PMID: 34140275]
  43. Mov Disord. 2021 May;36(5):1126-1136 [PMID: 33470460]

MeSH Term

Humans
Medulloblastoma
Child
Female
Male
Magnetic Resonance Imaging
Child, Preschool
Cerebellar Neoplasms
Adolescent
Glymphatic System
White Matter

Word Cloud

Created with Highcharts 10.0.0PVSchemotherapyvolumeratiomodelradiotherapypatients3M12ManesthesiashuntsignificantlyPerivascularfourtimeTPsmedulloblastomaMBbaselineFollowUpwhitematterMRIusingdatafullincludedpairedincreasedcompareddecreasedexhibitedundergoneprocedurespacespacesfluidfilledcompartmentssurroundingsmallbloodvesselsbrainimpactremainsunclearaimstudyinvestigatetreatmenteffectspointspediatricexamined778scans2410M12weeks3monthsrestcompletionfollow-up18-21-monthspost-baselinesegmentedapplyingFrangifilterregionsT1weightedimagesacquired3TSiemensscannerMPRAGEdefinedmeasuredfirststatisticallyanalyzedcompletedconsecutivemeasurementsconditionsshowedincludingpost-radiotherapySubsequentlyexamslowerwithoutPatientsreducedconcludedcraniospinalirradiationledelevatedConverselypost-irradiationAnesthesiaprocedurescanalsoinfluenceperivascularimagingtherapy

Similar Articles

Cited By